Close Asset Management’s Elevance Health ELV Stock Holding History

Close Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.37M	Sell	4,668 -1,673	-26%	-$550K	0.04%	75
2025 Q4	$2.22M	Sell	6,341 -482	-7%	-$163K	0.05%	71
2025 Q3	$2.21M	Sell	6,823 -368,370	-98%	-$115M	0.05%	70
2025 Q2	$146M	Buy	375,193 +190	+0.1%	+$76.4K	4.27%	6
2025 Q1	$163M	Buy	375,003 +1,456	+0.4%	+$584K	4.69%	5
2024 Q4	$138M	Hold	373,547	–	–	3.88%	10
2024 Q3	$194M	Buy	373,547 +4,214	+1%	+$2.25M	5.97%	4
2024 Q2	$200M	Buy	369,333 +77,571	+27%	+$41M	6.8%	3
2024 Q1	$151M	Buy	+291,762	New	+$145M	5.52%	4

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Close Asset Management's ELV Position: Q1 2026 in Review

Close Asset Management reduced its Elevance Health (ELV) stake by 26% in Q1 2026, selling an estimated $550K and leaving 4,668 shares worth $1.37M. The position accounts for 0.04% of the portfolio, ranked #75.

Close Asset Management first reported a position in ELV in Q1 2024 and has held it in 9 quarters since. The position peaked at $200M in Q2 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Close Asset Management held 4,668 shares of Elevance Health worth $1.37M as of Q1 2026.
Close Asset Management sold 1,673 Elevance Health shares in Q1 2026, an estimated $550K.
Elevance Health made up 0.04% of Close Asset Management's portfolio in Q1 2026, its #75 holding.
Close Asset Management first reported a position in Elevance Health in Q1 2024 and has held it in 9 quarters since.
Close Asset Management's Elevance Health position peaked at $200M in Q2 2024.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Close Asset Management's 13F filing for Q1 2026, filed 12 May 2026.